Bestard, Oriol <br/><br/>
Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.  [electronic resource] 

 -  Kidney international  Dec 2013 
 - 1226-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1038/ki.2013.236  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers--metabolism<br/>Biopsy<br/>DNA Methylation<br/>Drug Therapy, Combination<br/>Enzyme-Linked Immunospot Assay<br/>Female<br/>Forkhead Transcription Factors--genetics<br/>Graft Rejection--diagnosis<br/>Graft Survival--drug effects<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Immunologic Memory--drug effects<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon-gamma--metabolism<br/>Interferon-gamma Release Tests<br/>Isoantigens--immunology<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Risk Factors<br/>T-Lymphocytes--drug effects<br/>Time Factors<br/>Treatment Outcome